Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOAT2 | O75908 | 1/20 | 0.68 |
| ▸ | ACAT1 | P24752 | 1/20 | 0.68 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.68 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PLK1 | P53350 | 4/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8042246 | 0.92 | SOAT2 (0.67) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| SCHEMBL8416104 | 0.92 | SOAT2 (0.67) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| SCHEMBL8086038 | 0.90 | SOAT2 (0.59) | SOAT2ACAT1SOAT1ESR1PLK1 | |
| SCHEMBL8079964 | 0.87 | SOAT2 (0.56) | SOAT2ACAT1SOAT1ESR1PLK1 | |
| SCHEMBL8043445 | 0.87 | SOAT2 (0.69) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| SCHEMBL8043291 | 0.85 | SOAT2 (0.59) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| SCHEMBL8049344 | 0.85 | SOAT2 (0.67) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| SCHEMBL24482943 | 0.81 | SOAT2 (0.62) | SOAT2ACAT1SOAT1ESR1EPHX1 | |
| Eflucimibe SCHEMBL29427708 | 0.81 | SOAT2 (1.00) | SOAT2ACAT1SOAT1LMNAPLK1 | |
| Eflucimibe SCHEMBL668294 | 0.81 | SOAT2 (1.00) | SOAT2ACAT1SOAT1LMNAPLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0874812-B1 | NOVEL 2,3,5-TRIMETHYL-4-HYDROXY ANILIDE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTICAL USE THEREOF | PF MEDICAMENT (FR) | 2000-04-05 | — | — | EP | disclosed |
| US-5990173-A | ANTICHOLESTEROL AGENTS; TREATING ATHEROSCLEROSIS; ENZYME INHIBITORS OF ACYLCOENZYME A:CHOLESTEROL ACYLTRANSFERASE (ACAT) | PIERRE FABRE MEDICAMENT (FR) | 1999-11-23 | — | — | US | disclosed |